Respiratory Care Devices Market by Product (PAP Devices, Ventilators, Humidifiers, Oxygen Concentrators, Spirometers, Peak Flow Meter, Masks), Disease Indication (Asthma, Infectious Disease), End User (Hospitals, Homecare Settings) - Global Forecast to 2030

1 INTRODUCTION 37 1.1 STUDY OBJECTIVES 37 1.2 MARKET DEFINITION 37 1.2.1 INCLUSIONS AND EXCLUSIONS 38 1.3 MARKET SCOPE 39 1.3.1 MARKETS COVERED 39 1.3.2 YEARS CONSIDERED 40 1.4 CURRENCY CONSIDERED 40 1.5 STAKEHOLDERS 41 1.6 LIMITATIONS 41 1.7 SUMMARY OF CHANGES 41 2 RESEARCH METHODOLOGY 43 2.1 RESEARCH DATA 43 2.1.1 SECONDARY DATA 44 2.1.1.1 Key data from secondary sources 45 2.1.2 PRIMARY DATA 45 2.1.2.1 Key data from primary sources 47 2.1.2.2 Key industry insights 47 2.2 MARKET SIZE ESTIMATION 49 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 57 2.4 ASSUMPTIONS 58 2.4.1 MARKET SHARE ASSUMPTIONS 58 2.4.2 RESEARCH ASSUMPTIONS 58 2.5 RISK ASSESSMENT 58 2.6 METHODOLOGY-RELATED LIMITATIONS 58 3 EXECUTIVE SUMMARY 59 4 PREMIUM INSIGHTS 63 4.1 RESPIRATORY CARE DEVICES MARKET OVERVIEW 63 4.2 ASIA PACIFIC: RESPIRATORY CARE DEVICES MARKET, 2024 64 4.3 RESPIRATORY CARE DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 65 4.4 RESPIRATORY CARE DEVICES MARKET: GEOGRAPHIC MIX 65 4.5 RESPIRATORY CARE DEVICES MARKET: DEVELOPING VS. DEVELOPED MARKETS 66   5 MARKET OVERVIEW 67 5.1 INTRODUCTION 67 5.2 MARKET DYNAMICS 67 5.2.1 DRIVERS 68 5.2.1.1 Rising prevalence of respiratory diseases 68 5.2.1.1.1 Rapid growth in global geriatric population 68 5.2.1.1.2 Urbanization and growing pollution levels 69 5.2.1.1.3 Growing tobacco consumption 70 5.2.1.1.4 Increased adoption of sedentary lifestyles 71 5.2.1.2 Surging incidence rate of preterm births 71 5.2.1.3 Growing outbreaks of infectious diseases affecting respiratory systems 72 5.2.1.4 Rising population with sleep disorders 72 5.2.1.5 Improved patient outcomes using respiratory care devices 73 5.2.1.6 Rising R&D investments for technological advancement of medical devices 73 5.2.2 RESTRAINTS 74 5.2.2.1 Unfavorable reimbursement scenario for respiratory care diagnostics 74 5.2.2.2 Availability of low-cost products from local manufacturers 74 5.2.2.3 High cost of CPAP machines 75 5.2.3 OPPORTUNITIES 75 5.2.3.1 Growing demand for home care therapeutic devices 75 5.2.3.2 Market growth opportunities in Asia Pacific 76 5.2.3.3 Increasing preference for self-testing 76 5.2.3.4 Growing awareness about ill effects of untreated sleep apnea 77 5.2.4 CHALLENGES 78 5.2.4.1 Low awareness and lack of diagnosis of respiratory diseases 78 5.2.4.2 Harmful effects of certain respiratory care devices on neonates 78 5.2.4.3 Lack of patient compliance with CPAP therapy 79 5.3 REGULATORY LANDSCAPE 79 5.4 REGULATORY FRAMEWORK 79 5.4.1 NORTH AMERICA 79 5.4.1.1 US 79 5.4.1.2 Canada 80 5.4.2 EUROPE 80 5.4.3 ASIA PACIFIC 81 5.4.3.1 Japan 81 5.4.3.2 China 82 5.4.3.3 India 83 5.4.4 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 83   5.5 TECHNOLOGY ANALYSIS 85 5.5.1 KEY TECHNOLOGIES 85 5.5.1.1 OXYGEN THERAPY SYSTEMS 85 5.5.1.2 AIRWAY MANAGEMENT DEVICES 85 5.5.1.3 PULMONARY FUNCTION TESTING (PFT) DEVICES 85 5.5.1.4 MONITORING SENSORS 86 5.5.2 COMPLEMENTARY TECHNOLOGIES 86 5.5.2.1 TELEMEDICINE PLATFORMS 86 5.5.2.2 MOBILE HEALTH (MHEALTH) APPS 87 5.5.2.3 WEARABLE RESPIRATORY TRACKERS 87 5.5.3 ADJACENT TECHNOLOGIES 87 5.5.3.1 SMART INHALERS 87 5.5.3.2 ENVIRONMENTAL SENSING DEVICES 87 5.6 INDUSTRY TRENDS 88 5.6.1 MINIATURIZATION AND PORTABILITY 88 5.6.2 SMART CONNECTIVITY AND IOT (INTERNET OF THINGS) INTEGRATION 88 5.6.3 GROWING DEMAND FOR MULTIMODAL VENTILATION 89 5.6.4 RISING ADOPTION OF NON-INVASIVE VENTILATION 89 5.6.5 PERSONALIZED TREATMENT SOLUTIONS 90 5.7 VALUE CHAIN ANALYSIS 90 5.8 SUPPLY CHAIN ANALYSIS 91 5.9 TRADE ANALYSIS 92 5.9.1 TRADE ANALYSIS FOR RESPIRATORY CARE DEVICES PRODUCTS 92 5.10 PRICING ANALYSIS 93 5.10.1 AVERAGE SELLING PRICE OF RESPIRATORY CARE DEVICES, BY KEY PLAYER, 2024 (USD) 93 5.10.2 AVERAGE SELLING PRICE OF RESPIRATORY CARE DEVICES, BY REGION, 2024 (USD) 94 5.11 REIMBURSEMENT SCENARIO 94 5.12 PORTER’S FIVE FORCES ANALYSIS 95 5.12.1 THREAT OF NEW ENTRANTS 96 5.12.2 THREAT OF SUBSTITUTES 96 5.12.3 BARGAINING POWER OF SUPPLIERS 96 5.12.4 BARGAINING POWER OF BUYERS 97 5.12.5 INTENSITY OF COMPETITIVE RIVALRY 97 5.13 ADJACENT MARKET ANALYSIS 97 5.14 PATENT ANALYSIS 98 5.15 ECOSYSTEM COVERAGE 99 5.16 KEY CONFERENCES AND EVENTS (2025-2026) 100 5.17 KEY CONFERENCES & EVENTS DURING 2025-2026 100 5.18 CASE STUDIES 101 5.19 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 103 5.20 KEY STAKEHOLDERS & BUYING CRITERIA 104 5.20.1 KEY STAKEHOLDERS IN BUYING PROCESS 104 5.21 KEY BUYING CRITERIA 105 5.22 INVESTMENT/VENTURE CAPITAL 106 5.23 UNMET NEEDS/END-USER EXPECTATIONS IN RESPIRATORY CARE DEVICES MARKET 106 5.24 IMPACT OF ARTIFICIAL INTELLIGENCE (AI) ON RESPIRATORY CARE DEVICES MARKET 107 5.25 IMPACT OF 2025 US TARIFF – OVERVIEW 108 5.25.1 INTRODUCTION 108 5.26 KEY TARIFF RATES 109 5.27 PRICE IMPACT ANALYSIS 110 5.27.1 IMPACT ON COUNTRY/REGION 110 5.27.1.1 US 110 5.27.1.2 Europe 111 5.27.1.3 Asia Pacific 111 5.28 IMPACT ON END-USER INDUSTRIES 111 6 RESPIRATORY CARE DEVICES MARKET, BY PRODUCT 113 6.1 INTRODUCTION 114 6.2 THERAPEUTIC RESPIRATORY CARE DEVICES 115 6.2.1 PAP DEVICES 118 6.2.1.1 CPAP devices 120 6.2.1.1.1 Growing popularity of nasal CPAP therapies to drive demand 120 6.2.1.2 APAP devices 122 6.2.1.2.1 Rising awareness among sleep specialists and patients regarding additional features of APAP devices to boost market 122 6.2.1.3 BiPAP devices 124 6.2.1.3.1 Increasing number of hospitals to strengthen market 124 6.2.2 VENTILATORS 125 6.2.2.1 ICU ventilators 127 6.2.2.1.1 High-end ventilators 130 6.2.2.1.1.1 Improving healthcare infrastructure and rising healthcare expenditure to drive market 130 6.2.2.1.2 Mid-end ventilators 131 6.2.2.1.2.1 Better affordability and accessibility of mid-end ventilators than high-end models to support market growth 131 6.2.2.1.3 Basic ventilators 133 6.2.2.1.3.1 Expanding access to critical healthcare facilities in developing countries to spur demand 133 6.2.2.2 Portable/Transportable ventilators 134 6.2.2.2.1 Increasing demand for home care to boost segmental growth 134   6.2.3 NEBULIZERS 137 6.2.3.1 Jet nebulizers 140 6.2.3.1.1 Increasing prevalence of respiratory conditions to augment market 140 6.2.3.2 Mesh nebulizers 142 6.2.3.2.1 Deployment of advanced aerosolization technology to drive market 142 6.2.3.3 Ultrasonic nebulizers 143 6.2.3.3.1 Adjustable settings for particle size and treatment duration to boost market 143 6.2.4 HUMIDIFIERS 144 6.2.4.1 Heated humidifiers 145 6.2.4.1.1 Ease of control and customizability to fuel market 145 6.2.4.2 Passover humidifiers 148 6.2.4.2.1 Minimal maintenance and simple technology to spur demand 148 6.2.5 OXYGEN CONCENTRATORS 149 6.2.5.1 Fixed oxygen concentrators 151 6.2.5.1.1 Better access to healthcare services to spur demand 151 6.2.5.2 Portable oxygen concentrators 152 6.2.5.2.1 Low weight and easy setup to drive segmental growth 152 6.2.6 INHALERS 154 6.2.6.1 Metered-dose inhalers (MDIs) 155 6.2.6.1.1 Ongoing advancements in MDI technology to support market growth 155 6.2.6.2 Dry powder inhalers (DPIs) 157 6.2.6.2.1 Developments in particle engineering and powder formulations to boost segmental growth 157 6.2.7 REUSABLE RESUSCITATORS 158 6.2.7.1 Disposable and reusable nature to drive demand 158 6.2.8 NITRIC OXIDE DELIVERY UNITS 159 6.2.8.1 Rising emphasis of companies on developing innovative and advanced nitric oxide delivery units to drive market 159 6.2.9 OXYGEN HOODS 161 6.2.9.1 Growing prevalence of respiratory diseases in kids to drive market growth 161 6.3 MONITORING DEVICES 162 6.3.1 PULSE OXIMETERS 164 6.3.1.1 Pulse oximeter sensors 165 6.3.1.1.1 Development of advanced sensors with embedded chips to boost segmental growth 165 6.3.1.2 Pulse oximeter equipment 166 6.3.1.2.1 Growing prevalence of chronic respiratory conditions to boost demand 166   6.3.2 CAPNOGRAPHS 168 6.3.2.1 Ongoing R&D on capnographs to offer lucrative growth opportunities 168 6.3.3 GAS ANALYZERS 170 6.3.3.1 Increasing demand for point-of-care testing to drive demand 170 6.4 DIAGNOSTIC RESPIRATORY CARE DEVICES 171 6.4.1 SPIROMETERS 173 6.4.1.1 Rising technological advancements in spirometers to support market growth 173 6.4.2 POLYSOMNOGRAPHY DEVICES (PSG DEVICES) 175 6.4.2.1 Rising incidence of obstructive sleep apnea to drive demand 175 6.4.3 PEAK FLOW METERS 177 6.4.3.1 Low-cost and uncomplicated nature to drive segmental growth 177 6.4.4 OTHER DIAGNOSTIC DEVICES 178 6.5 CONSUMABLES & ACCESSORIES 180 6.5.1 MASKS 181 6.5.1.1 Reusable masks 183 6.5.1.1.1 Growing concerns related to air pollution to fuel demand 183 6.5.1.2 Disposable masks 184 6.5.1.2.1 Stringent government mandates on wearing masks to spur demand 184 6.5.2 DISPOSABLE RESUSCITATORS 185 6.5.2.1 Growing focus on reducing cross-contamination cases in patients to foster segmental growth 185 6.5.3 TRACHEOSTOMY TUBES 186 6.5.3.1 Introduction of advanced products with ergonomic designs to drive market growth 186 6.5.4 BREATHING CIRCUITS 188 6.5.4.1 Healthcare professionals’ efforts to improve infection control practices to drive demand 188 6.5.5 NASAL CANNULAE 189 6.5.5.1 Increasing focus on minimally invasive surgery techniques to fuel demand 189 6.5.6 OTHER CONSUMABLES & ACCESSORIES 191 7 RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION 192 7.1 INTRODUCTION 193 7.2 CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) 195 7.2.1 RISING INDOOR AND OUTDOOR AIR POLLUTION LEVELS TO DRIVE MARKET 195 7.3 SLEEP APNEA 196 7.3.1 GROWING INCIDENCE OF OBESITY AND CARDIOVASCULAR DISEASES TO FAVOR MARKET GROWTH 196 7.4 ASTHMA 199 7.4.1 INCREASING AIR POLLUTION AND GROWING USE OF TOBACCO-BASED PRODUCTS TO DRIVE MARKET 199 7.5 INFECTIOUS DISEASES 201 7.5.1 GROWING NUMBER OF TB PATIENTS TO BOOST MARKET GROWTH 201 7.6 OTHER DISEASE INDICATIONS 203 8 RESPIRATORY CARE DEVICES MARKET, BY END USER 204 8.1 INTRODUCTION 205 8.2 HOSPITALS 206 8.2.1 GROWING NUMBER OF HOSPITALS IN EMERGING ECONOMIES TO DRIVE MARKET 206 8.3 HOME CARE SETTINGS 208 8.3.1 INCREASING ACCEPTANCE OF HOME CARE DEVICES BY PATIENTS TO BOOST GROWTH 208 8.4 AMBULATORY CARE CENTERS (ACCS) 210 8.4.1 IMPROVED PATIENT EXPERIENCE IN AMBULATORY CARE CENTERS TO DRIVE MARKET 210 8.5 OTHER END USERS 211 9 RESPIRATORY CARE DEVICES MARKET, BY REGION 213 9.1 INTRODUCTION 214 9.2 NORTH AMERICA 215 9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 222 9.2.2 US 223 9.2.2.1 Rapid growth in geriatric population to boost market 223 9.2.3 CANADA 230 9.2.3.1 Large pool of undiagnosed patients and vaping trends drive market 230 9.3 EUROPE 237 9.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 243 9.3.2 GERMANY 244 9.3.2.1 Increasing public healthcare expenditure to foster market growth 244 9.3.3 FRANCE 251 9.3.3.1 High prevalence of COPD to surge demand 251 9.3.4 UK 257 9.3.4.1 Growing demand for minimally invasive surgeries to drive market 257 9.3.5 ITALY 263 9.3.5.1 Growing involvement of private sector in healthcare market to drive market 263 9.3.6 SPAIN 270 9.3.6.1 Need to improve healthcare infrastructure due to aging demographic to drive demand 270 9.3.7 REST OF EUROPE 276   9.4 ASIA PACIFIC 282 9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 290 9.4.2 JAPAN 291 9.4.2.1 Availability of universal healthcare reimbursement policy to drive market 291 9.4.3 CHINA 297 9.4.3.1 Initiatives to modernize healthcare system and reimbursement facilities to support market growth 297 9.4.4 INDIA 303 9.4.4.1 Increasing focus of global players on domestic market to drive market 303 9.4.5 AUSTRALIA 310 9.4.5.1 High prevalence of chronic lung diseases to drive demand 310 9.4.6 SOUTH KOREA 316 9.4.6.1 Expanding geriatric population to fuel market 316 9.4.7 REST OF ASIA PACIFIC 322 9.5 LATIN AMERICA 328 9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 334 9.5.2 BRAZIL 334 9.5.2.1 Government initiatives to improve healthcare sector to drive market 334 9.5.3 MEXICO 341 9.5.3.1 Rising obesity rate to increase incidence of respiratory diseases 341 9.5.4 REST OF LATIN AMERICA 347 9.6 MIDDLE EAST & AFRICA 353 9.6.1 MACROECONOMIC OUTLOOK FOR MEA 360 9.6.2 GCC COUNTRIES 361 9.6.2.1 INCREASING INCIDENCE OF RESPIRATORY DISEASES IN GCC DRIVES MARKET 361 9.6.3 REST OF MIDDLE EAST & AFRICA 367 10 COMPETITIVE LANDSCAPE 374 10.1 OVERVIEW 374 10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 374 10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN RESPIRATORY CARE DEVICES MARKET 375 10.3 REVENUE ANALYSIS 377 10.4 MARKET SHARE ANALYSIS 378 10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 380 10.5.1 STARS 381 10.5.2 EMERGING LEADERS 381 10.5.3 PERVASIVE PLAYERS 381 10.5.4 PARTICIPANTS 381 10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 383 10.5.5.1 Company footprint 383 10.5.5.2 Region footprint 384 10.5.5.3 Product type footprint 385 10.5.5.4 Disease indication footprint 386 10.5.5.5 End user footprint 387 10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 388 10.6.1 PROGRESSIVE COMPANIES 388 10.6.2 DYNAMIC COMPANIES 388 10.6.3 STARTING BLOCKS 388 10.6.4 RESPONSIVE COMPANIES 389 10.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 390 10.7 VALUATION & FINANCIAL METRICS 391 10.7.1 FINANCIAL METRICS 391 10.7.2 COMPANY VALUATION 391 10.8 BRAND/PRODUCT COMPARISON 392 10.9 COMPETITIVE SCENARIO 393 10.9.1 PRODUCT & SERVICE LAUNCHES AND APPROVALS 393 10.9.2 DEALS 394 10.9.3 EXPANSIONS 395 10.9.4 OTHER DEVELOPMENTS 395 11 COMPANY PROFILES 396 11.1 KEY PLAYERS 396 11.1.1 KONINKLIJKE PHILIPS N.V. 396 11.1.1.1 Business overview 396 11.1.1.2 Products offered 397 11.1.1.3 Recent developments 399 11.1.1.3.1 Product launches & approvals 399 11.1.1.4 MnM view 399 11.1.1.4.1 Right to win 399 11.1.1.4.2 Strategic choices 399 11.1.1.4.3 Weaknesses & competitive threats 400 11.1.2 MEDTRONIC 401 11.1.2.1 Business overview 401 11.1.2.2 Products offered 402 11.1.2.3 Recent developments 403 11.1.2.3.1 Product launches & approvals 403 11.1.2.3.2 Other developments 404 11.1.2.4 MnM view 404 11.1.2.4.1 Right to win 404 11.1.2.4.2 Strategic choices 404 11.1.2.4.3 Weaknesses & competitive threats 404   11.1.3 RESMED INC. 405 11.1.3.1 Business overview 405 11.1.3.2 Products offered 406 11.1.3.3 Recent developments 408 11.1.3.3.1 Product launches & approvals 408 11.1.3.3.2 Deals 409 11.1.3.4 MnM view 410 11.1.3.4.1 Right to win 410 11.1.3.4.2 Strategic choices 410 11.1.3.4.3 Weaknesses & competitive threats 410 11.1.4 FISHER & PAYKEL HEALTHCARE LIMITED 411 11.1.4.1 Business overview 411 11.1.4.2 Products offered 412 11.1.4.3 Recent developments 414 11.1.4.3.1 Product launches & approvals 414 11.1.4.4 MnM view 415 11.1.4.4.1 Right to win 415 11.1.4.4.2 Strategic choices 415 11.1.4.4.3 Weaknesses & competitive threats 416 11.1.5 DRÄGERWERK AG & CO. KGAA 417 11.1.5.1 Business overview 417 11.1.5.2 Products offered 418 11.1.5.3 Recent developments 419 11.1.5.3.1 Product launches & approvals 419 11.1.5.3.2 Deals 420 11.1.5.3.3 Other developments 420 11.1.5.4 MnM view 420 11.1.5.4.1 Right to win 420 11.1.5.4.2 Strategic choices 421 11.1.5.4.3 Weaknesses & competitive threats 421 11.1.6 MASIMO 422 11.1.6.1 Business overview 422 11.1.6.2 Products offered 423 11.1.6.3 Recent developments 425 11.1.6.3.1 Product launches & approvals 425 11.1.6.3.2 Deals 426 11.1.6.3.3 Other developments 426 11.1.7 GETINGE 427 11.1.7.1 Business overview 427 11.1.7.2 Products offered 428 11.1.7.3 Recent developments 429 11.1.7.3.1 Product launches & approvals 429 11.1.7.3.2 Deals 429 11.1.7.3.3 Expansions 430 11.1.8 NIHON KOHDEN CORPORATION 431 11.1.8.1 Business overview 431 11.1.8.2 Products offered 432 11.1.8.3 Recent developments 433 11.1.8.3.1 Product launches & approvals 433 11.1.8.3.2 Deals 434 11.1.9 GE HEALTHCARE 435 11.1.9.1 Business overview 435 11.1.9.2 Products offered 436 11.1.9.3 Recent developments 437 11.1.9.3.1 Deals 437 11.1.9.3.2 Other developments 437 11.1.10 HILLROM & WELCH ALLYN (BAXTER INTERNATIONAL, INC) 438 11.1.10.1 Business overview 438 11.1.10.2 Products offered 439 11.1.10.3 Recent developments 440 11.1.10.3.1 Product launches & approvals 440 11.1.10.3.2 Deals 441 11.1.11 ADAPTHEALTH, LLC 442 11.1.11.1 Business overview 442 11.1.11.2 Products offered 443 11.1.12 TELEFLEX INCORPORATED 444 11.1.12.1 Business overview 444 11.1.12.2 Products offered 445 11.1.13 AIR LIQUIDE 446 11.1.13.1 Business overview 446 11.1.13.2 Products offered 447 11.1.13.3 Recent developments 449 11.1.13.3.1 Deals 449 11.1.14 ICU MEDICAL, INC. 450 11.1.14.1 Business overview 450 11.1.14.2 Products offered 451 11.1.14.3 Recent developments 452 11.1.14.3.1 Product launches & approvals 452 11.1.14.3.2 Deals 452 11.1.15 HAMILTON MEDICAL 453 11.1.15.1 Business overview 453 11.1.15.2 Products offered 453 11.1.15.3 Recent developments 454 11.1.15.3.1 Product launches & approvals 454 11.2 OTHER PLAYERS 455 11.2.1 MEDLINE INDUSTRIES, LP 455 11.2.2 ALLIED MEDICAL LLC 457 11.2.3 NONIN 458 11.2.4 APEX MEDICAL 459 11.2.5 ROTECH HEALTHCARE, INC. 460 11.2.6 LÖWENSTEIN MEDICAL SE & CO. KG 461 11.2.7 WEINMANN EMERGENCY MEDICAL TECHNOLOGY GMBH + CO. KG 462 11.2.8 DRIVE DEVILBISS HEALTHCARE 463 11.2.9 OMRON HEALTHCARE, INC. 464 11.2.10 HUM GMBH 465 12 APPENDIX 466 12.1 DISCUSSION GUIDE 466 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 471 12.3 CUSTOMIZATION OPTIONS 473 12.4 RELATED REPORTS 473 12.5 AUTHOR DETAILS 474

TABLE 1 ANNUAL AVERAGE EXCHANGE RATE FOR CURRENCY CONVERSION, 2020–2024 40 TABLE 2 RESEARCH ASSUMPTIONS 58 TABLE 3 RISK ASSESSMENT: RESPIRATORY CARE DEVICES MARKET 58 TABLE 4 REGION-WISE DATA ON LIFESTYLE DISEASES 70 TABLE 5 TOP 10 COUNTRIES WITH HIGHEST RATES OF PRETERM BIRTH PER 100 LIVE BIRTHS 71 TABLE 6 PRODUCT LAUNCHES 74 TABLE 7 INITIATIVES TO PROMOTE AWARENESS ABOUT UNTREATED SLEEP APNEA 77 TABLE 8 US: CLASSIFICATION OF MEDICAL EQUIPMENT 79 TABLE 9 US: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 80 TABLE 10 CANADA: LEVEL OF RISK, TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 80 TABLE 11 EUROPE: LEVEL OF RISK, TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 81 TABLE 12 JAPAN: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 82 TABLE 13 CHINA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS 82 TABLE 14 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 83 TABLE 15 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 83 TABLE 16 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 84 TABLE 17 IMPORT DATA FOR RESPIRATORY CARE DEVICES (HS CODE 901920), BY COUNTRY, 2020–2024 (USD THOUSAND) 92 TABLE 18 EXPORT DATA FOR RESPIRATORY CARE DEVICES (HS CODE 901920), BY COUNTRY, 2020–2024 (USD THOUSAND) 93 TABLE 19 RESPIRATORY CARE DEVICES MARKET: REIMBURSEMENT SCENARIO 94 TABLE 20 RESPIRATORY CARE DEVICES MARKET: PORTERS FIVE FORCE ANALYSIS 96 TABLE 21 RESPIRATORY CARE DEVICES MARKET: DETAILED LIST OF CONFERENCES & EVENTS 100 TABLE 22 CASE STUDY 1: LONG-TERM VENTILATION WITH VARIABLE PSV 101 TABLE 23 CASE STUDY 2: OPTIMAL UTILIZATION OF MECHANICAL VENTILATOR AT TERTIARY CARE HOSPITAL DURING COVID-19 PANDEMIC 102 TABLE 24 CASE STUDY 3: CHANGING PATTERNS IN LONG-TERM NON-INVASIVE VENTILATION 103 TABLE 25 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR RESPIRATORY CARE DEVICES 105 TABLE 26 KEY BUYING CRITERIA FOR RESPIRATORY CARE DEVICES 105 TABLE 27 RESPIRATORY CARE DEVICES MARKET: UNMET NEEDS 106 TABLE 28 RESPIRATORY CARE DEVICES MARKET: APPLICATION OF ARTIFICIAL INTELLIGENCE 107 TABLE 29 US-ADJUSTED RECIPROCAL TARIFF RATES 109 TABLE 30 KEY PRODUCT-RELATED TARIFF EFFECTIVE FOR RESPIRATORY CARE DEVICES 110 TABLE 31 RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 114 TABLE 32 RESPIRATORY CARE DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 115 TABLE 33 THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 116 TABLE 34 THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 117 TABLE 35 PAP DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 118 TABLE 36 PAP DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 119 TABLE 37 PAP DEVICES MARKET, BY REGION, 2023–2030 (THOUSAND UNITS) 119 TABLE 38 MAJOR PLAYERS OFFERING CPAP DEVICES 120 TABLE 39 CPAP DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 121 TABLE 40 MAJOR PLAYERS OFFERING APAP DEVICES 122 TABLE 41 APAP DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 123 TABLE 42 MAJOR PLAYERS OFFERING BIPAP DEVICES 124 TABLE 43 BIPAP DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 125 TABLE 44 VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 126 TABLE 45 VENTILATORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 126 TABLE 46 VENTILATORS MARKET, BY REGION, 2023–2030 (THOUSAND UNITS) 127 TABLE 47 MAJOR PLAYERS OFFERING ICU VENTILATORS 128 TABLE 48 ICU VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 129 TABLE 49 ICU VENTILATORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 129 TABLE 50 HIGH-END VENTILATORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 131 TABLE 51 MID-END VENTILATORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 132 TABLE 52 BASIC VENTILATORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 133 TABLE 53 MAJOR PLAYERS OFFERING PORTABLE/TRANSPORTABLE VENTILATORS 134 TABLE 54 PORTABLE/TRANSPORTABLE VENTILATORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 136 TABLE 55 MAJOR PLAYERS OFFERING NEBULIZERS 137 TABLE 56 NEBULIZERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 138 TABLE 57 NEBULIZERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 139 TABLE 58 NEBULIZERS MARKET, BY REGION, 2023–2030 (THOUSAND UNITS) 140 TABLE 59 JET NEBULIZERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 141 TABLE 60 MESH NEBULIZERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 142 TABLE 61 ULTRASONIC NEBULIZERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 143 TABLE 62 HUMIDIFIERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 144 TABLE 63 HUMIDIFIERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 145 TABLE 64 MAJOR PLAYERS OFFERING HEATED HUMIDIFIERS 146 TABLE 65 HEATED HUMIDIFIERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 147 TABLE 66 MAJOR PLAYERS OFFERING PASSOVER HUMIDIFIERS 148 TABLE 67 PASSOVER HUMIDIFIERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 149 TABLE 68 MAJOR PLAYERS OFFERING OXYGEN CONCENTRATORS 150 TABLE 69 OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 150 TABLE 70 OXYGEN CONCENTRATORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 151 TABLE 71 FIXED OXYGEN CONCENTRATORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 152 TABLE 72 PORTABLE OXYGEN CONCENTRATORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 153 TABLE 73 INHALERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 154 TABLE 74 INHALERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 155 TABLE 75 METERED-DOSE INHALERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 156 TABLE 76 DRY POWDER INHALERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 157 TABLE 77 MAJOR PLAYERS OFFERING REUSABLE RESUSCITATORS 158 TABLE 78 REUSABLE RESUSCITATORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 159 TABLE 79 MAJOR PLAYERS OFFERING NITRIC OXIDE DELIVERY UNITS 160 TABLE 80 NITRIC OXIDE DELIVERY UNITS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 160 TABLE 81 MAJOR PLAYERS OFFERING OXYGEN HOODS 161 TABLE 82 OXYGEN HOODS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 162 TABLE 83 RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 163 TABLE 84 RESPIRATORY CARE MONITORING DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 163 TABLE 85 MAJOR PLAYERS OFFERING PULSE OXIMETERS 164 TABLE 86 PULSE OXIMETERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 164 TABLE 87 PULSE OXIMETERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 165 TABLE 88 PULSE OXIMETER SENSORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 166 TABLE 89 MAJOR PLAYERS OFFERING PULSE OXIMETER EQUIPMENT 167 TABLE 90 PULSE OXIMETER EQUIPMENT MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 168 TABLE 91 MAJOR PLAYERS OFFERING CAPNOGRAPHS 169 TABLE 92 CAPNOGRAPHS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 169 TABLE 93 MAJOR PLAYERS OFFERING GAS ANALYZERS 170 TABLE 94 GAS ANALYZERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 171 TABLE 95 DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 172 TABLE 96 DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 172 TABLE 97 MAJOR PLAYERS OFFERING SPIROMETERS 173 TABLE 98 SPIROMETERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 174 TABLE 99 SPIROMETERS MARKET, BY REGION, 2023–2030 (THOUSAND UNITS) 175 TABLE 100 MAJOR PLAYERS OFFERING POLYSOMNOGRAPHY DEVICES 175 TABLE 101 POLYSOMNOGRAPHY DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 176 TABLE 102 MAJOR PLAYERS OFFERING PEAK FLOW METERS 177 TABLE 103 PEAK FLOW METERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 178 TABLE 104 OTHER DIAGNOSTIC DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 179 TABLE 105 RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 180 TABLE 106 RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 181 TABLE 107 MASKS MARKET, BY TYPE, 2023–2030 (USD MILLION) 182 TABLE 108 MASKS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 182 TABLE 109 REUSABLE MASKS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 183 TABLE 110 DISPOSABLE MASKS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 185 TABLE 111 DISPOSABLE RESUSCITATORS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 186 TABLE 112 TRACHEOSTOMY TUBES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 187 TABLE 113 BREATHING CIRCUITS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 189 TABLE 114 NASAL CANNULAE MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 190 TABLE 115 OTHER CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 191 TABLE 116 RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2023–2030 (USD MILLION) 193 TABLE 117 DISEASE INDICATION: RESPIRATORY CARE DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 194 TABLE 118 RESPIRATORY CARE DEVICES MARKET FOR COPD, BY COUNTRY, 2023–2030 (USD MILLION) 196 TABLE 119 COUNTRY-WISE DATA ON SLEEP APNEA PATIENTS 197 TABLE 120 RESPIRATORY CARE DEVICES MARKET FOR SLEEP APNEA, BY COUNTRY, 2023–2030 (USD MILLION) 198 TABLE 121 RESPIRATORY CARE DEVICES MARKET FOR ASTHMA, BY COUNTRY, 2023–2030 (USD MILLION) 200 TABLE 122 INCIDENCE OF TB (RATE PER 100,000 POPULATION) 201 TABLE 123 RESPIRATORY CARE DEVICES MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2023–2030 (USD MILLION) 202 TABLE 124 RESPIRATORY CARE DEVICES MARKET FOR OTHER DISEASE INDICATIONS, BY COUNTRY, 2023–2030 (USD MILLION) 203 TABLE 125 RESPIRATORY CARE DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 205 TABLE 126 END USER: RESPIRATORY CARE DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 205 TABLE 127 RESPIRATORY CARE DEVICES MARKET FOR HOSPITALS, BY COUNTRY, 2023–2030 (USD MILLION) 207 TABLE 128 RESPIRATORY CARE DEVICES MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2023–2030 (USD MILLION) 209 TABLE 129 RESPIRATORY CARE DEVICES MARKET FOR AMBULATORY CARE CENTERS, BY COUNTRY, 2023–2030 (USD MILLION) 211 TABLE 130 RESPIRATORY CARE DEVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION) 212 TABLE 131 RESPIRATORY CARE DEVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 215 TABLE 132 NORTH AMERICA: RESPIRATORY CARE DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 216 TABLE 133 NORTH AMERICA: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 217 TABLE 134 NORTH AMERICA: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 217 TABLE 135 NORTH AMERICA: PAP DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 218 TABLE 136 NORTH AMERICA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 218 TABLE 137 NORTH AMERICA: VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 218 TABLE 138 NORTH AMERICA: ICU VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 219 TABLE 139 NORTH AMERICA: INHALERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 219 TABLE 140 NORTH AMERICA: HUMIDIFIERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 219 TABLE 141 NORTH AMERICA: NEBULIZERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 220 TABLE 142 NORTH AMERICA: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 220 TABLE 143 NORTH AMERICA: PULSE OXIMETERS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 220 TABLE 144 NORTH AMERICA: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 221 TABLE 145 NORTH AMERICA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 221 TABLE 146 NORTH AMERICA: MASKS MARKET, BY TYPE, 2023–2030 (USD MILLION) 221 TABLE 147 NORTH AMERICA: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2023–2030 (USD MILLION) 222 TABLE 148 NORTH AMERICA: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 222 TABLE 149 US: KEY MACROINDICATORS 224 TABLE 150 US: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 224 TABLE 151 US: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 225 TABLE 152 US: PAP DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 225 TABLE 153 US: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 225 TABLE 154 US: VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 226 TABLE 155 US: ICU VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 226 TABLE 156 US: INHALERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 226 TABLE 157 US: HUMIDIFIERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 227 TABLE 158 US: NEBULIZERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 227 TABLE 159 US: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 227 TABLE 160 US: PULSE OXIMETERS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 228 TABLE 161 US: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 228 TABLE 162 US: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 228 TABLE 163 US: MASKS MARKET, BY TYPE, 2023–2030 (USD MILLION) 229 TABLE 164 US: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2023–2030 (USD MILLION) 229 TABLE 165 US: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 229 TABLE 166 CANADA: COPD AND ASTHMA STATISTICS (2019 VS. 2020) 230 TABLE 167 CANADA: KEY MACROINDICATORS 231 TABLE 168 CANADA: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 231 TABLE 169 CANADA: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 232 TABLE 170 CANADA: PAP DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 232 TABLE 171 CANADA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 232 TABLE 172 CANADA: VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 233 TABLE 173 CANADA: ICU VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 233 TABLE 174 CANADA: INHALERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 233 TABLE 175 CANADA: HUMIDIFIERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 234 TABLE 176 CANADA: NEBULIZERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 234 TABLE 177 CANADA: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 234 TABLE 178 CANADA: PULSE OXIMETERS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 235 TABLE 179 CANADA: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 235 TABLE 180 CANADA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 235 TABLE 181 CANADA: MASKS MARKET, BY TYPE, 2023–2030 (USD MILLION) 236 TABLE 182 CANADA: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2023–2030 (USD MILLION) 236 TABLE 183 CANADA: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 236 TABLE 184 EUROPE: RESPIRATORY CARE DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 237 TABLE 185 EUROPE: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 238 TABLE 186 EUROPE: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 238 TABLE 187 EUROPE: PAP DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 239 TABLE 188 EUROPE: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 239 TABLE 189 EUROPE: VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 239 TABLE 190 EUROPE: ICU VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 240 TABLE 191 EUROPE: INHALERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 240 TABLE 192 EUROPE: HUMIDIFIERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 240 TABLE 193 EUROPE: NEBULIZERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 241 TABLE 194 EUROPE: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 241 TABLE 195 EUROPE: PULSE OXIMETERS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 241 TABLE 196 EUROPE: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 242 TABLE 197 EUROPE: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 242 TABLE 198 EUROPE: MASKS MARKET, BY TYPE, 2023–2030 (USD MILLION) 242 TABLE 199 EUROPE: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2023–2030 (USD MILLION) 243 TABLE 200 EUROPE: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 243 TABLE 201 GERMANY: KEY MACROINDICATORS 245 TABLE 202 GERMANY: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 245 TABLE 203 GERMANY: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 246 TABLE 204 GERMANY: PAP DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 246 TABLE 205 GERMANY: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 246 TABLE 206 GERMANY: VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 247 TABLE 207 GERMANY: ICU VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 247 TABLE 208 GERMANY: INHALERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 247 TABLE 209 GERMANY: HUMIDIFIERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 248 TABLE 210 GERMANY: NEBULIZERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 248 TABLE 211 GERMANY: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 248 TABLE 212 GERMANY: PULSE OXIMETERS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 249 TABLE 213 GERMANY: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 249 TABLE 214 GERMANY: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 249 TABLE 215 GERMANY: MASKS MARKET, BY TYPE, 2023–2030 (USD MILLION) 250 TABLE 216 GERMANY: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2023–2030 (USD MILLION) 250 TABLE 217 GERMANY: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 250 TABLE 218 FRANCE: KEY MACROINDICATORS 251 TABLE 219 FRANCE: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 251 TABLE 220 FRANCE: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 252 TABLE 221 FRANCE: PAP DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 252 TABLE 222 FRANCE: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 252 TABLE 223 FRANCE: VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 253 TABLE 224 FRANCE: ICU VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 253 TABLE 225 FRANCE: INHALERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 253 TABLE 226 FRANCE: HUMIDIFIERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 254 TABLE 227 FRANCE: NEBULIZERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 254 TABLE 228 FRANCE: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 254 TABLE 229 FRANCE: PULSE OXIMETERS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 255 TABLE 230 FRANCE: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 255 TABLE 231 FRANCE: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 255 TABLE 232 FRANCE: MASKS MARKET, BY TYPE, 2023–2030 (USD MILLION) 256 TABLE 233 FRANCE: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2023–2030 (USD MILLION) 256 TABLE 234 FRANCE: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 256 TABLE 235 UK: KEY MACROINDICATORS 257 TABLE 236 UK: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 258 TABLE 237 UK: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 258 TABLE 238 UK: PAP DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 259 TABLE 239 UK: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 259 TABLE 240 UK: VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 259 TABLE 241 UK: ICU VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 260 TABLE 242 UK: INHALERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 260 TABLE 243 UK: HUMIDIFIERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 260 TABLE 244 UK: NEBULIZERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 261 TABLE 245 UK: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 261 TABLE 246 UK: PULSE OXIMETERS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 261 TABLE 247 UK: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 262 TABLE 248 UK: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 262 TABLE 249 UK: MASKS MARKET, BY TYPE, 2023–2030 (USD MILLION) 262 TABLE 250 UK: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2023–2030 (USD MILLION) 263 TABLE 251 UK: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 263 TABLE 252 ITALY: KEY MACROINDICATORS 264 TABLE 253 ITALY: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 264 TABLE 254 ITALY: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 265 TABLE 255 ITALY: PAP DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 265 TABLE 256 ITALY: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 265 TABLE 257 ITALY: VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 266 TABLE 258 ITALY: ICU VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 266 TABLE 259 ITALY: INHALERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 266 TABLE 260 ITALY: HUMIDIFIERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 267 TABLE 261 ITALY: NEBULIZERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 267 TABLE 262 ITALY: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 267 TABLE 263 ITALY: PULSE OXIMETERS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 268 TABLE 264 ITALY: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 268 TABLE 265 ITALY: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 268 TABLE 266 ITALY: MASKS MARKET, BY TYPE, 2023–2030 (USD MILLION) 269 TABLE 267 ITALY: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2023–2030 (USD MILLION) 269 TABLE 268 ITALY: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 269 TABLE 269 SPAIN: KEY MACROINDICATORS 270 TABLE 270 SPAIN: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 271 TABLE 271 SPAIN: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 271 TABLE 272 SPAIN: PAP DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 272 TABLE 273 SPAIN: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 272 TABLE 274 SPAIN: VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 272 TABLE 275 SPAIN: ICU VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 273 TABLE 276 SPAIN: INHALERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 273 TABLE 277 SPAIN: HUMIDIFIERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 273 TABLE 278 SPAIN: NEBULIZERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 274 TABLE 279 SPAIN: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 274 TABLE 280 SPAIN: PULSE OXIMETERS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 274 TABLE 281 SPAIN: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 275 TABLE 282 SPAIN: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 275 TABLE 283 SPAIN: MASKS MARKET, BY TYPE, 2023–2030 (USD MILLION) 275 TABLE 284 SPAIN: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2023–2030 (USD MILLION) 276 TABLE 285 SPAIN: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 276 TABLE 286 REST OF EUROPE: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 277 TABLE 287 REST OF EUROPE: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 277 TABLE 288 REST OF EUROPE: PAP DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 278 TABLE 289 REST OF EUROPE: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 278 TABLE 290 REST OF EUROPE: VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 278 TABLE 291 REST OF EUROPE: ICU VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 279 TABLE 292 REST OF EUROPE: INHALERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 279 TABLE 293 REST OF EUROPE: HUMIDIFIERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 279 TABLE 294 REST OF EUROPE: NEBULIZERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 280 TABLE 295 REST OF EUROPE: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 280 TABLE 296 REST OF EUROPE: PULSE OXIMETERS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 280 TABLE 297 REST OF EUROPE: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 281 TABLE 298 REST OF EUROPE: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 281 TABLE 299 REST OF EUROPE: MASKS MARKET, BY TYPE, 2023–2030 (USD MILLION) 281 TABLE 300 REST OF EUROPE: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2023–2030 (USD MILLION) 282 TABLE 301 REST OF EUROPE: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 282 TABLE 302 ASIA PACIFIC: RESPIRATORY CARE DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 284 TABLE 303 ASIA PACIFIC: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 284 TABLE 304 ASIA PACIFIC: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 285 TABLE 305 ASIA PACIFIC: PAP DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 285 TABLE 306 ASIA PACIFIC: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 285 TABLE 307 ASIA PACIFIC: VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 286 TABLE 308 ASIA PACIFIC: ICU VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 286 TABLE 309 ASIA PACIFIC: INHALERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 286 TABLE 310 ASIA PACIFIC: HUMIDIFIERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 287 TABLE 311 ASIA PACIFIC: NEBULIZERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 287 TABLE 312 ASIA PACIFIC: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 287 TABLE 313 ASIA PACIFIC: PULSE OXIMETERS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 288 TABLE 314 ASIA PACIFIC: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 288 TABLE 315 ASIA PACIFIC: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 288 TABLE 316 ASIA PACIFIC: MASKS MARKET, BY TYPE, 2023–2030 (USD MILLION) 289 TABLE 317 ASIA PACIFIC: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2023–2030 (USD MILLION) 289 TABLE 318 ASIA PACIFIC: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 289 TABLE 319 JAPAN: KEY MACROINDICATORS 291 TABLE 320 JAPAN: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 291 TABLE 321 JAPAN: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 292 TABLE 322 JAPAN: PAP DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 292 TABLE 323 JAPAN: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 292 TABLE 324 JAPAN: VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 293 TABLE 325 JAPAN: ICU VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 293 TABLE 326 JAPAN: INHALERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 293 TABLE 327 JAPAN: HUMIDIFIERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 294 TABLE 328 JAPAN: NEBULIZERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 294 TABLE 329 JAPAN: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 294 TABLE 330 JAPAN: PULSE OXIMETERS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 295 TABLE 331 JAPAN: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 295 TABLE 332 JAPAN: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 295 TABLE 333 JAPAN: MASKS MARKET, BY TYPE, 2023–2030 (USD MILLION) 296 TABLE 334 JAPAN: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2023–2030 (USD MILLION) 296 TABLE 335 JAPAN: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 296 TABLE 336 CHINA: KEY MACROINDICATORS 297 TABLE 337 CHINA: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 298 TABLE 338 CHINA: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 298 TABLE 339 CHINA: PAP DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 299 TABLE 340 CHINA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 299 TABLE 341 CHINA: VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 299 TABLE 342 CHINA: ICU VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 300 TABLE 343 CHINA: INHALERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 300 TABLE 344 CHINA: HUMIDIFIERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 300 TABLE 345 CHINA: NEBULIZERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 301 TABLE 346 CHINA: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 301 TABLE 347 CHINA: PULSE OXIMETERS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 301 TABLE 348 CHINA: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 302 TABLE 349 CHINA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 302 TABLE 350 CHINA: MASKS MARKET, BY TYPE, 2023–2030 (USD MILLION) 302 TABLE 351 CHINA: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2023–2030 (USD MILLION) 303 TABLE 352 CHINA: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 303 TABLE 353 INDIA: KEY MACROINDICATORS 304 TABLE 354 INDIA: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 304 TABLE 355 INDIA: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 305 TABLE 356 INDIA: PAP DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 305 TABLE 357 INDIA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 305 TABLE 358 INDIA: VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 306 TABLE 359 INDIA: ICU VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 306 TABLE 360 INDIA: INHALERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 306 TABLE 361 INDIA: HUMIDIFIERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 307 TABLE 362 INDIA: NEBULIZERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 307 TABLE 363 INDIA: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 307 TABLE 364 INDIA: PULSE OXIMETERS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 308 TABLE 365 INDIA: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 308 TABLE 366 INDIA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 308 TABLE 367 INDIA: MASKS MARKET, BY TYPE, 2023–2030 (USD MILLION) 309 TABLE 368 INDIA: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2023–2030 (USD MILLION) 309 TABLE 369 INDIA: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 309 TABLE 370 AUSTRALIA: KEY MACROINDICATORS 310 TABLE 371 AUSTRALIA: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 310 TABLE 372 AUSTRALIA: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 311 TABLE 373 AUSTRALIA: PAP DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 311 TABLE 374 AUSTRALIA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 311 TABLE 375 AUSTRALIA: VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 312 TABLE 376 AUSTRALIA: ICU VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 312 TABLE 377 AUSTRALIA: INHALERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 312 TABLE 378 AUSTRALIA: HUMIDIFIERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 313 TABLE 379 AUSTRALIA: NEBULIZERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 313 TABLE 380 AUSTRALIA: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 313 TABLE 381 AUSTRALIA: PULSE OXIMETERS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 314 TABLE 382 AUSTRALIA: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 314 TABLE 383 AUSTRALIA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 314 TABLE 384 AUSTRALIA: MASKS MARKET, BY TYPE, 2023–2030 (USD MILLION) 315 TABLE 385 AUSTRALIA: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2023–2030 (USD MILLION) 315 TABLE 386 AUSTRALIA: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 315 TABLE 387 SOUTH KOREA: KEY MACROINDICATORS 316 TABLE 388 SOUTH KOREA: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 316 TABLE 389 SOUTH KOREA: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 317 TABLE 390 SOUTH KOREA: PAP DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 317 TABLE 391 SOUTH KOREA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 317 TABLE 392 SOUTH KOREA: VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 318 TABLE 393 SOUTH KOREA: ICU VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 318 TABLE 394 SOUTH KOREA: INHALERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 318 TABLE 395 SOUTH KOREA: HUMIDIFIERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 319 TABLE 396 SOUTH KOREA: NEBULIZERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 319 TABLE 397 SOUTH KOREA: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 319 TABLE 398 SOUTH KOREA: PULSE OXIMETERS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 320 TABLE 399 SOUTH KOREA: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 320 TABLE 400 SOUTH KOREA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 320 TABLE 401 SOUTH KOREA: MASKS MARKET, BY TYPE, 2023–2030 (USD MILLION) 321 TABLE 402 SOUTH KOREA: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2023–2030 (USD MILLION) 321 TABLE 403 SOUTH KOREA: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 321 TABLE 404 REST OF ASIA PACIFIC: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 322 TABLE 405 REST OF ASIA PACIFIC: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 323 TABLE 406 REST OF ASIA PACIFIC: PAP DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 323 TABLE 407 REST OF ASIA PACIFIC: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 323 TABLE 408 REST OF ASIA PACIFIC: VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 324 TABLE 409 REST OF ASIA PACIFIC: ICU VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 324 TABLE 410 REST OF ASIA PACIFIC: INHALERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 324 TABLE 411 REST OF ASIA PACIFIC: HUMIDIFIERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 325 TABLE 412 REST OF ASIA PACIFIC: NEBULIZERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 325 TABLE 413 REST OF ASIA PACIFIC: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 325 TABLE 414 REST OF ASIA PACIFIC: PULSE OXIMETERS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 326 TABLE 415 REST OF ASIA PACIFIC: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 326 TABLE 416 REST OF ASIA PACIFIC: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 326 TABLE 417 REST OF ASIA PACIFIC: MASKS MARKET, BY TYPE, 2023–2030 (USD MILLION) 327 TABLE 418 REST OF ASIA PACIFIC: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2023–2030 (USD MILLION) 327 TABLE 419 REST OF ASIA PACIFIC: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 327 TABLE 420 LATIN AMERICA: RESPIRATORY CARE DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 328 TABLE 421 LATIN AMERICA: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 328 TABLE 422 LATIN AMERICA: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 329 TABLE 423 LATIN AMERICA: PAP DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 329 TABLE 424 LATIN AMERICA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 329 TABLE 425 LATIN AMERICA: VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 330 TABLE 426 LATIN AMERICA: ICU VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 330 TABLE 427 LATIN AMERICA: INHALERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 330 TABLE 428 LATIN AMERICA: HUMIDIFIERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 331 TABLE 429 LATIN AMERICA: NEBULIZERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 331 TABLE 430 LATIN AMERICA: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 331 TABLE 431 LATIN AMERICA: PULSE OXIMETERS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 332 TABLE 432 LATIN AMERICA: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 332 TABLE 433 LATIN AMERICA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 332 TABLE 434 LATIN AMERICA: MASKS MARKET, BY TYPE, 2023–2030 (USD MILLION) 333 TABLE 435 LATIN AMERICA: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2023–2030 (USD MILLION) 333 TABLE 436 LATIN AMERICA: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 333 TABLE 437 BRAZIL: KEY MACROINDICATORS 335 TABLE 438 BRAZIL: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 335 TABLE 439 BRAZIL: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 336 TABLE 440 BRAZIL: PAP DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 336 TABLE 441 BRAZIL: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 336 TABLE 442 BRAZIL: VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 337 TABLE 443 BRAZIL: ICU VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 337 TABLE 444 BRAZIL: INHALERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 337 TABLE 445 BRAZIL: HUMIDIFIERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 338 TABLE 446 BRAZIL: NEBULIZERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 338 TABLE 447 BRAZIL: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 338 TABLE 448 BRAZIL: PULSE OXIMETERS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 339 TABLE 449 BRAZIL: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 339 TABLE 450 BRAZIL: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 339 TABLE 451 BRAZIL: MASKS MARKET, BY TYPE, 2023–2030 (USD MILLION) 340 TABLE 452 BRAZIL: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2023–2030 (USD MILLION) 340 TABLE 453 BRAZIL: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 340 TABLE 454 MEXICO: KEY MACROINDICATORS 341 TABLE 455 MEXICO: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 341 TABLE 456 MEXICO: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 342 TABLE 457 MEXICO: PAP DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 342 TABLE 458 MEXICO: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 342 TABLE 459 MEXICO: VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 343 TABLE 460 MEXICO: ICU VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 343 TABLE 461 MEXICO: INHALERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 343 TABLE 462 MEXICO: HUMIDIFIERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 344 TABLE 463 MEXICO: NEBULIZERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 344 TABLE 464 MEXICO: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 344 TABLE 465 MEXICO: PULSE OXIMETERS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 345 TABLE 466 MEXICO: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 345 TABLE 467 MEXICO: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 345 TABLE 468 MEXICO: MASKS MARKET, BY TYPE, 2023–2030 (USD MILLION) 346 TABLE 469 MEXICO: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2023–2030 (USD MILLION) 346 TABLE 470 MEXICO: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 346 TABLE 471 REST OF LATIN AMERICA: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 347 TABLE 472 REST OF LATIN AMERICA: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 348 TABLE 473 REST OF LATIN AMERICA: PAP DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 348 TABLE 474 REST OF LATIN AMERICA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 348 TABLE 475 REST OF LATIN AMERICA: VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 349 TABLE 476 REST OF LATIN AMERICA: ICU VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 349 TABLE 477 REST OF LATIN AMERICA: INHALERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 349 TABLE 478 REST OF LATIN AMERICA: HUMIDIFIERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 350 TABLE 479 REST OF LATIN AMERICA: NEBULIZERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 350 TABLE 480 REST OF LATIN AMERICA: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 350 TABLE 481 REST OF LATIN AMERICA: PULSE OXIMETERS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 351 TABLE 482 REST OF LATIN AMERICA: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 351 TABLE 483 REST OF LATIN AMERICA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 352 TABLE 484 REST OF LATIN AMERICA: MASKS MARKET, BY TYPE, 2023–2030 (USD MILLION) 352 TABLE 485 REST OF LATIN AMERICA: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2023–2030 (USD MILLION) 353 TABLE 486 REST OF LATIN AMERICA: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 353 TABLE 487 MIDDLE EAST & AFRICA: RESPIRATORY CARE DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 354 TABLE 488 MIDDLE EAST & AFRICA: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 354 TABLE 489 MIDDLE EAST & AFRICA: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 355 TABLE 490 MIDDLE EAST & AFRICA: PAP DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 355 TABLE 491 MIDDLE EAST & AFRICA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 355 TABLE 492 MIDDLE EAST & AFRICA: VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 356 TABLE 493 MIDDLE EAST & AFRICA: ICU VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 356 TABLE 494 MIDDLE EAST & AFRICA: INHALERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 356 TABLE 495 MIDDLE EAST & AFRICA: HUMIDIFIERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 357 TABLE 496 MIDDLE EAST & AFRICA: NEBULIZERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 357 TABLE 497 MIDDLE EAST & AFRICA: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 357 TABLE 498 MIDDLE EAST & AFRICA: PULSE OXIMETERS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 358 TABLE 499 MIDDLE EAST & AFRICA: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 358 TABLE 500 MIDDLE EAST & AFRICA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 359 TABLE 501 MIDDLE EAST & AFRICA: MASKS MARKET, BY TYPE, 2023–2030 (USD MILLION) 359 TABLE 502 MIDDLE EAST & AFRICA: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2023–2030 (USD MILLION) 360 TABLE 503 MIDDLE EAST & AFRICA: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 360 TABLE 504 GCC COUNTRIES: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 362 TABLE 505 GCC COUNTRIES: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 362 TABLE 506 GCC COUNTRIES: PAP DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 363 TABLE 507 GCC COUNTRIES: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 363 TABLE 508 GCC COUNTRIES: VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 363 TABLE 509 GCC COUNTRIES: ICU VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 364 TABLE 510 GCC COUNTRIES: INHALERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 364 TABLE 511 GCC COUNTRIES: HUMIDIFIERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 364 TABLE 512 GCC COUNTRIES: NEBULIZERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 365 TABLE 513 GCC COUNTRIES: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 365 TABLE 514 GCC COUNTRIES: PULSE OXIMETERS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 365 TABLE 515 GCC COUNTRIES: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 366 TABLE 516 GCC COUNTRIES: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 366 TABLE 517 GCC COUNTRIES: MASKS MARKET, BY TYPE, 2023–2030 (USD MILLION) 366 TABLE 518 GCC COUNTRIES: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2023–2030 (USD MILLION) 367 TABLE 519 GCC COUNTRIES: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 367 TABLE 520 REST OF MIDDLE EAST & AFRICA: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 368 TABLE 521 REST OF MIDDLE EAST & AFRICA: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 368 TABLE 522 REST OF MIDDLE EAST & AFRICA: PAP DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 369 TABLE 523 REST OF MIDDLE EAST & AFRICA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 369 TABLE 524 REST OF MIDDLE EAST & AFRICA: VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 369 TABLE 525 REST OF MIDDLE EAST & AFRICA: ICU VENTILATORS MARKET, BY TYPE, 2023–2030 (USD MILLION) 370 TABLE 526 REST OF MIDDLE EAST & AFRICA: INHALERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 370 TABLE 527 REST OF MIDDLE EAST & AFRICA: HUMIDIFIERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 370 TABLE 528 REST OF MIDDLE EAST & AFRICA: NEBULIZERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 371 TABLE 529 REST OF MIDDLE EAST & AFRICA: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 371 TABLE 530 REST OF MIDDLE EAST & AFRICA: PULSE OXIMETERS MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 371 TABLE 531 REST OF MIDDLE EAST & AFRICA: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2023–2030 (USD MILLION) 372 TABLE 532 REST OF MIDDLE EAST & AFRICA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 372 TABLE 533 REST OF MIDDLE EAST & AFRICA: MASKS MARKET, BY TYPE, 2023–2030 (USD MILLION) 372 TABLE 534 REST OF MIDDLE EAST & AFRICA: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2023–2030 (USD MILLION) 373 TABLE 535 REST OF MIDDLE EAST & AFRICA: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 373 TABLE 536 STRATEGIES ADOPTED BY KEY PLAYERS IN RESPIRATORY CARE DEVICES MARKET, JANUARY 2021–APRIL 2025 375 TABLE 537 RESPIRATORY CARE DEVICES MARKET: DEGREE OF COMPETITION 379 TABLE 538 RESPIRATORY CARE DEVICES MARKET: REGION FOOTPRINT 384 TABLE 539 RESPIRATORY CARE DEVICES MARKET: PRODUCT TYPE FOOTPRINT 385 TABLE 540 RESPIRATORY CARE DEVICES MARKET: DISEASE INDICATION FOOTPRINT 386 TABLE 541 RESPIRATORY CARE DEVICES MARKET: END USER FOOTPRINT 387 TABLE 542 RESPIRATORY CARE DEVICES MARKET: DETAILED LIST OF KEY STARTUPS/SMES 390 TABLE 543 RESPIRATORY CARE DEVICES MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 390 TABLE 544 RESPIRATORY CARE DEVICES MARKET: PRODUCT & SERVICE LAUNCHES AND APPROVALS, JANUARY 2021–APRIL 2025 393 TABLE 545 RESPIRATORY CARE DEVICES MARKET: DEALS, JANUARY 2021–APRIL 2025 394 TABLE 546 RESPIRATORY CARE DEVICES MARKET: EXPANSIONS, JANUARY 2021–APRIL 2025 395 TABLE 547 RESPIRATORY CARE DEVICES MARKET: OTHER DEVELOPMENTS, JANUARY 2021– APRIL 2025 395 TABLE 548 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW 396 TABLE 549 KONINKLIJKE PHILIPS N.V.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–APRIL 2025 399 TABLE 550 MEDTRONIC: COMPANY OVERVIEW 401 TABLE 551 MEDTRONIC PLC: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–APRIL 2025 403 TABLE 552 MEDTRONIC PLC: OTHER DEVELOPMENTS, JANUARY 2021–APRIL 2025 404 TABLE 553 RESMED INC.: COMPANY OVERVIEW 405 TABLE 554 RESMED INC: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–APRIL 2025 408 TABLE 555 RESMED INC: DEALS, JANUARY 2021–APRIL 2025 409 TABLE 556 FISHER & PAYKEL HEALTHCARE LIMITED: COMPANY OVERVIEW 411 TABLE 557 FISHER & PAYKEL HEALTHCARE LIMITED: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–APRIL 2025 414 TABLE 558 DRÄGERWERK AG & CO. KGAA: COMPANY OVERVIEW 417 TABLE 559 DRÄGERWERK AG & CO. KGAA: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–APRIL 2025 419 TABLE 560 DRÄGERWERK AG & CO. KGAA: DEALS, JANUARY 2021–APRIL 2025 420 TABLE 561 DRÄGERWERK AG & CO. KGAA: OTHER DEVELOPMENTS, JANUARY 2021–APRIL 2025 420 TABLE 562 MASIMO: COMPANY OVERVIEW 422 TABLE 563 MASIMO: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–APRIL 2025 425 TABLE 564 MASIMO: DEALS, JANUARY 2021–APRIL 2025 426 TABLE 565 MASIMO: OTHER DEVELOPMENTS, JANUARY 2021–APRIL 2025 426 TABLE 566 GETINGE: COMPANY OVERVIEW 427 TABLE 567 GETINGE: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–APRIL 2025 429 TABLE 568 GETINGE: DEALS, JANUARY 2021–APRIL 2025 429 TABLE 569 GETINGE: EXPANSIONS, JANUARY 2021–APRIL 2025 430 TABLE 570 NIHON KOHDEN CORPORATION: COMPANY OVERVIEW 431 TABLE 571 NIHON KOHDEN CORPORATION: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–APRIL 2025 433 TABLE 572 NIHON KOHDEN CORPORATION: DEALS, JANUARY 2021–APRIL 2025 434 TABLE 573 GE HEALTHCARE: COMPANY OVERVIEW 435 TABLE 574 GE HEALTHCARE: DEALS, JANUARY 2021–APRIL 2025 437 TABLE 575 GE HEALTHCARE: OTHER DEVELOPMENTS, JANUARY 2021–MARCH 2025 437 TABLE 576 HILLROM & WELCH ALLYN (BAXTER): COMPANY OVERVIEW 438 TABLE 577 HILLROM & WELCH ALLYN (BAXTER): PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–MARCH 2024 440 TABLE 578 HILLROM & WELCH ALLYN (BAXTER): DEALS, JANUARY 2021–MARCH 2024 441 TABLE 579 ADAPTHEALTH, LLC: COMPANY OVERVIEW 442 TABLE 580 TELEFLEX INCORPORATED: COMPANY OVERVIEW 444 TABLE 581 AIR LIQUIDE: COMPANY OVERVIEW 446 TABLE 582 AIR LIQUIDE: DEALS, JANUARY 2021–APRIL 2025 449 TABLE 583 ICU MEDICAL, INC.: COMPANY OVERVIEW 450 TABLE 584 ICU MEDICAL, INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–APRIL 2025 452 TABLE 585 ICU MEDICAL, INC.: DEALS, JANUARY 2021–MARCH 2024 452 TABLE 586 HAMILTON MEDICAL: COMPANY OVERVIEW 453 TABLE 587 HAMILTON MEDICAL: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–MARCH 2024 454 FIGURE 1 RESPIRATORY CARE DEVICES MARKET SEGMENTATION 39 FIGURE 2 RESEARCH DESIGN 43 FIGURE 3 PRIMARY SOURCES 46 FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 48 FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE), BY COMPANY TYPE, DESIGNATION, AND REGION 48 FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE), BY END USER, DESIGNATION, AND REGION 49 FIGURE 7 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 50 FIGURE 8 REVENUE SHARE ANALYSIS ILLUSTRATION: RESMED INC. 50 FIGURE 9 SUPPLY-SIDE MARKET ESTIMATION: RESPIRATORY CARE DEVICES MARKET (2024) 51 FIGURE 10 DEMAND-SIDE MARKET ESTIMATION: RESPIRATORY CARE DEVICES MARKET (2024) 52 FIGURE 11 TOTAL MARKET SIZE ESTIMATION: RESPIRATORY CARE DEVICES MARKET 52 FIGURE 12 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2025–2030) 54 FIGURE 13 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 55 FIGURE 14 TOP-DOWN APPROACH 56 FIGURE 15 MARKET DATA TRIANGULATION METHODOLOGY 57 FIGURE 16 RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2025 VS. 2030 (USD MILLION) 59 FIGURE 17 RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2025 VS. 2030 (USD MILLION) 60 FIGURE 18 RESPIRATORY CARE DEVICES MARKET, BY END USER, 2025 VS. 2030 (USD MILLION) 60 FIGURE 19 GEOGRAPHIC SNAPSHOT: RESPIRATORY CARE DEVICES MARKET 61 FIGURE 20 RISING PREVALENCE OF RESPIRATORY DISEASES TO DRIVE MARKET GROWTH DURING FORECAST PERIOD 63 FIGURE 21 INDIA ACCOUNTED FOR LARGEST SHARE OF RESPIRATORY CARE DEVICES MARKET IN ASIA PACIFIC IN 2024 64 FIGURE 22 INDIA TO GROW AT HIGHEST RATE DURING FORECAST PERIOD 65 FIGURE 23 NORTH AMERICA WILL CONTINUE TO DOMINATE RESPIRATORY CARE DEVICES MARKET DURING FORECAST PERIOD 65 FIGURE 24 DEVELOPING MARKETS TO REGISTER FASTEST GROWTH DURING FORECAST PERIOD 66 FIGURE 25 RESPIRATORY CARE DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 67 FIGURE 26 GLOBAL GERIATRIC POPULATION, BY REGION 69 FIGURE 27 ANNUAL DATA OF DEATHS CAUSED BY HOUSEHOLD AND AMBIENT AIR POLLUTION, BY DISEASE 70 FIGURE 28 IMPACT OF INNOVATIVE SOLUTIONS 89 FIGURE 29 INTRODUCTION OF INNOVATIVE SOLUTIONS FOR SLEEP APNEA TREATMENT 90 FIGURE 30 VALUE CHAIN ANALYSIS 91 FIGURE 31 SUPPLY CHAIN ANALYSIS 92 FIGURE 32 ADJACENT MARKETS FOR RESPIRATORY CARE DEVICES MARKET 97 FIGURE 33 TOP PATENT APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR RESPIRATORY CARE DEVICES MARKET 98 FIGURE 34 TOP PATENT APPLICANT COUNTRIES FOR RESPIRATORY CARE DEVICES (JANUARY 2014–DECEMBER 2024) 99 FIGURE 35 RESPIRATORY CARE DEVICES MARKET: ECOSYSTEM MARKET MAP 100 FIGURE 36 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES IN RESPIRATORY CARE DEVICES MARKET 104 FIGURE 37 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR RESPIRATORY CARE DEVICES 104 FIGURE 38 KEY BUYING CRITERIA FOR RESPIRATORY CARE DEVICES 105 FIGURE 39 RESPIRATORY CARE DEVICES MARKET: REGIONAL GROWTH OPPORTUNITIES 214 FIGURE 40 NORTH AMERICA: RESPIRATORY CARE DEVICES MARKET SNAPSHOT 216 FIGURE 41 ASIA PACIFIC: RESPIRATORY CARE DEVICES MARKET SNAPSHOT 283 FIGURE 42 REVENUE SHARE ANALYSIS OF KEY PLAYERS IN RESPIRATORY CARE DEVICES MARKET (2020−2024) 377 FIGURE 43 RESPIRATORY CARE DEVICES MARKET SHARE ANALYSIS, BY KEY PLAYER (2024) 378 FIGURE 44 RESPIRATORY CARE DEVICES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 382 FIGURE 45 RESPIRATORY CARE DEVICES MARKET: COMPANY FOOTPRINT 383 FIGURE 46 RESPIRATORY CARE DEVICES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 389 FIGURE 47 EV/EBITDA OF KEY VENDORS 391 FIGURE 48 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 391 FIGURE 49 RESPIRATORY CARE DEVICES MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 392 FIGURE 50 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2024) 397 FIGURE 51 MEDTRONIC: COMPANY SNAPSHOT (2024) 402 FIGURE 52 RESMED INC.: COMPANY SNAPSHOT (2024) 406 FIGURE 53 FISHER & PAYKEL HEALTHCARE LIMITED: COMPANY SNAPSHOT (2024) 412 FIGURE 54 DRÄGERWERK AG & CO. KGAA: COMPANY SNAPSHOT (2024) 418 FIGURE 55 MASIMO: COMPANY SNAPSHOT (2024) 423 FIGURE 56 GETINGE: COMPANY SNAPSHOT (2024) 428 FIGURE 57 NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT (2023) 432 FIGURE 58 GE HEALTHCARE: COMPANY SNAPSHOT (2024) 436 FIGURE 59 HILLROM & WELCH ALLYN (BAXTER): COMPANY SNAPSHOT (2024) 439 FIGURE 60 ADAPTHEALTH, LLC: COMPANY SNAPSHOT (2024) 442 FIGURE 61 TELEFLEX INCORPORATED: COMPANY SNAPSHOT (2024) 445 FIGURE 62 AIR LIQUIDE: COMPANY SNAPSHOT (2024) 447 FIGURE 63 ICU MEDICAL, INC.: COMPANY SNAPSHOT (2024) 451